辅助利法素与 gentamicin 在假内心炎中因金黄色葡萄球菌引起的治疗效果的比较
Taito Kitano1,2, Sayaka Yoshida1,2
1Department of Paediatrics, Nara Prefecture General Medical Centre, Nara, Japan.
JAC-antimicrobial resistance
|December 18, 2025
概括
与没有瑞芬素的瑞芬素相比,在没有瑞芬素的瑞芬素的辅助治疗中,在Staphylococcus aureus假肢内心炎患者中降低了一年死亡率. 对于这种情况,可能不需要常规 Gentamicin.
科学领域:
- 传染性疾病 传染性疾病
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有限的证据表明,辅助的利法素和/或 gentamicin 对于 Staphylococcus aureus 假内心炎的临床有效性.
- 黄金菌假内心炎是一种严重的疾病,需要有效的治疗策略.
研究的目的:
- 为了比较没有 gentamicin 的辅助 rifampicin 与没有 rifampicin 的辅助 gentamicin 在 S. aureus 假内心炎的临床影响.
- 评估与不同辅助抗生素治疗方案相关的死亡率和发病率结果.
主要方法:
- 使用TrinetX分析多中心电子医疗记录 (2016-2024) 的回顾性研究.
- 倾向性得分匹配被用来平衡患者的特征.
- 对于各种结果,估计了95%CI的危险比率 (HRs).
主要成果:
- 利芬素组的一年全因死亡率明显较低 (31.3%),相比 Gentamicin 组 (39.9%) (HR 0.71;P=0.016).
- 两组之间在ICU入院,复发性内心炎,功能衰竭或肝功能衰竭方面没有观察到统计学意义上的差异.
- 总共有353名患者接受了利芬素,369名患者接受了珍塔素.
结论:
- 与不含瑞芬素的含瑞芬素治疗方案相比,含瑞芬素的治疗方案与不含瑞芬素的治疗方案相比,含瑞芬素的治疗方案与减少的一年死亡率有关.
- 研究结果表明,对于S. aureus假内心炎,可能不需要常规使用辅助珍塔素.
- 由于潜在的残留混因素,应谨慎解释结果.
相关概念视频
Endocarditis III: Medical Management
197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
215
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
215
Endocarditis I: Introduction
362
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
362
Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Endocarditis IV: Nursing Management
297
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
297
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
165
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
165


